anmelden
Equifax Aktie
157,65
EUR
+1,40
EUR
+0,90
%
181,96
USD
+0,83
USD
+0,46
%
Equifax jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Equifax Aktie Analyse
| 13.11.17 | Equifax Hold | Stifel, Nicolaus & Co., Inc. | |
| 19.09.17 | Equifax Outperform | RBC Capital Markets | |
| 22.03.17 | Equifax Buy | Stifel, Nicolaus & Co., Inc. | |
| 10.02.17 | Equifax overweight | Barclays Capital | |
| 10.02.17 | Equifax Buy | Stifel, Nicolaus & Co., Inc. | |
| 05.12.16 | Equifax Outperform | Robert W. Baird & Co. Incorporated | |
| 28.10.16 | Equifax Outperform | RBC Capital Markets | |
| 29.04.16 | Equifax overweight | Barclays Capital | |
|
Werbung
|
|||
| 26.04.16 | Equifax Outperform | RBC Capital Markets | |
| 12.04.16 | Equifax Buy | Stifel, Nicolaus & Co., Inc. | |
| 23.10.15 | Equifax Buy | Stifel, Nicolaus & Co., Inc. | |
| 04.08.15 | Equifax Outperform | RBC Capital Markets | |
| 24.04.15 | Equifax overweight | Barclays Capital | |
| 05.02.15 | Equifax Buy | Deutsche Bank AG | |
| 08.06.12 | Equifax outperform | RBC Capital Markets | |
| 21.10.05 | Equifax Market Outperform | JMP Securities | |
| 07.09.05 | Equifax Outperform | William Blair | |
| 02.03.05 | Equifax Outperform | Robert W. Baird | |
Werbung
Werbung
